Modulating the Immune System
Home
About
Active Biotech in Brief
Board of Directors
Management
Business Concept
Corporate Governance
Corporate Governance Report 2019
Article of Association
Audit committee
Scientific committee
Election Committee
General Meetings
Auditors
Partnerships
Career
Projects
Project Overview
Naptumomab
Tasquinimod
Laquinimod
Patents
Orphan Drug Designation
Investor
Investor
Analyst coverage
Financial Calendar
Financial Reports
Interim Reports
Annual Reports
Stock
Ownership
Official Documents
Rights Issue 2014
Rights Issue 2016
Rights Issue 2018
Rights Issue 2021
Media
Press Contact
Press Releases
Subscribe
News
Company Presentation
Image Bank
Contact
Copyright © 2021 Active Biotech AB.
All Rights Reserved.
Design by
Clavis Communications
.
Investor
Investor
Analyst coverage
Financial Calendar
Financial Reports
Stock
Ownership
Official Documents
Financial Calendar
February 11, 2021, Year-end report 2020
April 22, 2021, Interim report
May 19, 2021, Annual General Meeting
August 5, 2021, Interim report
November 4, 2021, Interim report
This site uses cookies.
Okay, thanks
